hosted by
publicationslist.org
    

Mark J Cowley

Pancreatic Cancer Group
Garvan Institute of Medical Research
384 Victoria Street
Darlinghurst NSW 2010
AUSTRALIA
m.cowley@garvan.org.au

Journal articles

2012
Sanjay Swaminathan, Kazuo Suzuki, Nabila Seddiki, Warren Kaplan, Mark J Cowley, Chantelle L Hood, Jennifer L Clancy, Daniel D Murray, Catalina Méndez, Linda Gelgor, Ben Anderson, Norman Roth, David A Cooper, Anthony D Kelleher (2012)  Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression.   J Immunol 188: 12. 6238-6246 Jun  
Abstract: MicroRNAs (miRNAs) are ∼22-nt small RNAs that are important regulators of mRNA turnover and translation. Recent studies have shown the importance of the miRNA pathway in HIV-1 infection, particularly in maintaining latency. Our initial in vitro studies demonstrated that HIV-1-infected HUT78 cells expressed significantly higher IL-10 levels compared with uninfected cultures. IL-10 plays an important role in the dysregulated cytotoxic T cell response to HIV-1, and in silico algorithms suggested that let-7 miRNAs target IL10 mRNA. In a time course experiment, we demonstrated that let-7 miRNAs fall rapidly following HIV-1 infection in HUT78 cells with concomitant rises in IL-10. To show a direct link between let-7 and IL-10, forced overexpression of let-7 miRNAs resulted in significantly reduced IL-10 levels, whereas inhibition of the function of these miRNAs increased IL-10. To demonstrate the relevance of these results, we focused our attention on CD4(+) T cells from uninfected healthy controls, chronic HIV-1-infected patients, and long-term nonprogressors. We characterized miRNA changes in CD4(+) T cells from these three groups and demonstrated that let-7 miRNAs were highly expressed in CD4(+) T cells from healthy controls and let-7 miRNAs were significantly decreased in chronic HIV-1 infected compared with both healthy controls and long-term nonprogressors. We describe a novel mechanism whereby IL-10 levels can be potentially modulated by changes to let-7 miRNAs. In HIV-1 infection, the decrease in let-7 miRNAs may result in an increase in IL-10 from CD4(+) T cells and provide the virus with an important survival advantage by manipulating the host immune response.
Notes:
Mark J Cowley, Mark Pinese, Karin S Kassahn, Nic Waddell, John V Pearson, Sean M Grimmond, Andrew V Biankin, Sampsa Hautaniemi, Jianmin Wu (2012)  PINA v2.0: mining interactome modules.   Nucleic Acids Res 40: Database issue. D862-D865 Jan  
Abstract: The Protein Interaction Network Analysis (PINA) platform is a comprehensive web resource, which includes a database of unified protein-protein interaction data integrated from six manually curated public databases, and a set of built-in tools for network construction, filtering, analysis and visualization. The second version of PINA enhances its utility for studies of protein interactions at a network level, by including multiple collections of interaction modules identified by different clustering approaches from the whole network of protein interactions ('interactome') for six model organisms. All identified modules are fully annotated by enriched Gene Ontology terms, KEGG pathways, Pfam domains and the chemical and genetic perturbations collection from MSigDB. Moreover, a new tool is provided for module enrichment analysis in addition to simple query function. The interactome data are also available on the web site for further bioinformatics analysis. PINA is freely accessible at http://cbg.garvan.unsw.edu.au/pina/.
Notes:
Mark J Cowley, Anita Weinberg, Nathan Zammit, Stacey N Walters, Wayne J Hawthorne, Thomas Loudovaris, Helen Thomas, Tom Kay, Jenny E Gunton, Stephen I Alexander, Warren Kaplan, Jeremy Chapman, Philip J O'Connell, Shane T Grey (2012)  HUMAN ISLETS EXPRESS A MARKED PRO-INFLAMMATORY MOLECULAR SIGNATURE PRIOR TO TRANSPLANTATION.   Cell Transplant Mar  
Abstract: : In the context of islet transplantation, experimental models show that induction of islet intrinsic NF-κB-dependent pro-inflammatory genes can contribute to islet graft rejection. Isolation of human islets triggers activation of the NF-κB and mitogen-activated kinase (MAPK) stress response pathways. However, the down stream NF-κB-target genes induced in human islets during the isolation process are poorly described. Therefore in this study, using microarray, bioinformatic, and RTqPCR approaches, we determined the pattern of genes expressed by a set of 14 human islet preparations. We found that isolated human islets express a panel of genes reminiscent of cells undergoing a marked NF- κB-dependent pro-inflammatory response. Expressed genes included; matrix metallopeptidase 1 (MMP1) and Fibronectin 1 (FN1), factors involved in tissue remodelling, adhesion and cell migration; inflammatory cytokines IL-1 β and IL-8; genes regulating cell survival including A20 and ATF3; and notably high expression of a set of chemokines that would favour neutrophil and monocyte recruitment including CXCL2, CCL2, CXCL12, CXCL1, CXCL6, CCL28. Of note, the inflammatory profile of isolated human islets was maintained after transplantation into RAG-/- recipients. Thus human islets can provide a reservoir of NF- κBdependent inflammatory factors that have the potential to contribute to the anti-islet-graft immune response. To test this hypothesis we extracted rodent islets under optimal conditions, forced activation of NF- κB, and transplanted them into allogenic recipients. These NF- κB activated islets not only expressed the same chemokine profile observed in human islets, but also struggled to maintain normoglycemia post transplantation. Further, NF- κB activated islets were rejected with a faster tempo as compared to non-NF- κB-activated rodent islets. Thus isolated human islets can make cell autonomous contributions to the ensuing allograft response by elaborating inflammatory factors that contribute to their own demise. These data highlight the potential importance of islet intrinsic pro-inflammatory responses as targets for therapeutic intervention.
Notes:
Nicola Cooley, Mark J Cowley, Ruby C Y Lin, Silvana Marasco, Chiew Wong, David M Kaye, Anthony M Dart, Elizabeth A Woodcock (2012)  Influence of atrial fibrillation on microRNA expression profiles in left and right atria from patients with valvular heart disease.   Physiol Genomics 44: 3. 211-219 Feb  
Abstract: Chronic atrial fibrillation (AF) is a complication associated with the dilated atria of patients with valvular heart disease and contributes to worsened pathology. We examined microRNA (miRNA) expression profiles in right and left atrial appendage tissue from valvular heart disease (VHD) patients. Right atrial (RA) appendage from patients undergoing coronary artery bypass grafting and left atrial (LA) appendage from healthy hearts, not used for transplant, were used as controls. There was no detectable effect of chronic AF on miRNA expression in LA tissue, but miRNA expression in RA was strongly influenced by AF, with 47 miRNAs (15 higher, 32 lower) showing differential expression between the AF and control sinus rhythm groups. VHD induced different changes in miRNA expression in LA compared with RA. Fifty-three (12 higher, 41 lower) miRNAs were altered by VHD in LA, compared with 5 (4 higher, 1 lower) in RA tissue. miRNA profiles also differed between VHD-LA and VHD-RA (13 higher, 26 lower). We conclude that VHD and AF influence miRNA expression patterns in LA and RA, but these are affected differently by disease progression and by the development of AF. These findings provide new insights into the progression of VHD.
Notes:
Karen M Mann, Jerrold M Ward, Christopher Chin Kuan Yew, Anne Kovochich, David W Dawson, Michael A Black, Benjamin T Brett, Todd E Sheetz, Adam J Dupuy, Australian Pancreatic Cancer Genome Initiative, David K Chang, Andrew V Biankin, Nicola Waddell, Karin S Kassahn, Sean M Grimmond, Alistair G Rust, David J Adams, Nancy A Jenkins, Neal G Copeland (2012)  Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.   Proc Natl Acad Sci U S A 109: 16. 5934-5941 Apr  
Abstract: Pancreatic cancer is one of the most deadly cancers affecting the Western world. Because the disease is highly metastatic and difficult to diagnosis until late stages, the 5-y survival rate is around 5%. The identification of molecular cancer drivers is critical for furthering our understanding of the disease and development of improved diagnostic tools and therapeutics. We have conducted a mutagenic screen using Sleeping Beauty (SB) in mice to identify new candidate cancer genes in pancreatic cancer. By combining SB with an oncogenic Kras allele, we observed highly metastatic pancreatic adenocarcinomas. Using two independent statistical methods to identify loci commonly mutated by SB in these tumors, we identified 681 loci that comprise 543 candidate cancer genes (CCGs); 75 of these CCGs, including Mll3 and Ptk2, have known mutations in human pancreatic cancer. We identified point mutations in human pancreatic patient samples for another 11 CCGs, including Acvr2a and Map2k4. Importantly, 10% of the CCGs are involved in chromatin remodeling, including Arid4b, Kdm6a, and Nsd3, and all SB tumors have at least one mutated gene involved in this process; 20 CCGs, including Ctnnd1, Fbxo11, and Vgll4, are also significantly associated with poor patient survival. SB mutagenesis provides a rich resource of mutations in potential cancer drivers for cross-comparative analyses with ongoing sequencing efforts in human pancreatic adenocarcinoma.
Notes:
Pedro A Pérez-Mancera, Alistair G Rust, Louise van der Weyden, Glen Kristiansen, Allen Li, Aaron L Sarver, Kevin A T Silverstein, Robert Grützmann, Daniela Aust, Petra Rümmele, Thomas Knösel, Colin Herd, Derek L Stemple, Ross Kettleborough, Jacqueline A Brosnan, Ang Li, Richard Morgan, Spencer Knight, Jun Yu, Shane Stegeman, Lara S Collier, Jelle J ten Hoeve, Jeroen de Ridder, Alison P Klein, Michael Goggins, Ralph H Hruban, David K Chang, Andrew V Biankin, Sean M Grimmond, Australian Pancreatic Cancer Genome Initiative, Lodewyk F A Wessels, Stephen A Wood, Christine A Iacobuzio-Donahue, Christian Pilarsky, David A Largaespada, David J Adams, David A Tuveson (2012)  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma.   Nature 486: 7402. 266-270 Jun  
Abstract: Pancreatic ductal adenocarcinoma (PDA) remains a lethal malignancy despite much progress concerning its molecular characterization. PDA tumours harbour four signature somatic mutations in addition to numerous lower frequency genetic events of uncertain significance. Here we use Sleeping Beauty (SB) transposon-mediated insertional mutagenesis in a mouse model of pancreatic ductal preneoplasia to identify genes that cooperate with oncogenic Kras(G12D) to accelerate tumorigenesis and promote progression. Our screen revealed new candidate genes for PDA and confirmed the importance of many genes and pathways previously implicated in human PDA. The most commonly mutated gene was the X-linked deubiquitinase Usp9x, which was inactivated in over 50% of the tumours. Although previous work had attributed a pro-survival role to USP9X in human neoplasia, we found instead that loss of Usp9x enhances transformation and protects pancreatic cancer cells from anoikis. Clinically, low USP9X protein and messenger RNA expression in PDA correlates with poor survival after surgery, and USP9X levels are inversely associated with metastatic burden in advanced disease. Furthermore, chromatin modulation with trichostatin A or 5-aza-2'-deoxycytidine elevates USP9X expression in human PDA cell lines, indicating a clinical approach for certain patients. The conditional deletion of Usp9x cooperated with Kras(G12D) to accelerate pancreatic tumorigenesis in mice, validating their genetic interaction. We propose that USP9X is a major tumour suppressor gene with prognostic and therapeutic relevance in PDA.
Notes:
Sarah Song, Katia Nones, David Miller, Ivon Harliwong, Karin S Kassahn, Mark Pinese, Marina Pajic, Anthony J Gill, Amber L Johns, Matthew Anderson, Oliver Holmes, Conrad Leonard, Darrin Taylor, Scott Wood, Qinying Xu, Felicity Newell, Mark J Cowley, Jianmin Wu, Peter Wilson, Lynn Fink, Andrew V Biankin, Nic Waddell, Sean M Grimmond, John V Pearson (2012)  qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles.   PLoS One 7: 9. 09  
Abstract: Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; however this method is both subjective and prone to error due to heterogeneity within lesions and cellularity differences between the sample viewed during pathological review and tissue used for research purposes. In this paper we describe a statistical model to estimate tumour cellularity from SNP array profiles of paired tumour and normal samples using shifts in SNP allele frequency at regions of loss of heterozygosity (LOH) in the tumour. We also provide qpure, a software implementation of the method. Our experiments showed that there is a medium correlation 0.42 ([Formula: see text]-value = 0.0001) between tumor cellularity estimated by qpure and pathology review. Interestingly there is a high correlation 0.87 ([Formula: see text]-value [Formula: see text] 2.2e-16) between cellularity estimates by qpure and deep Ion Torrent sequencing of known somatic KRAS mutations; and a weaker correlation 0.32 ([Formula: see text]-value = 0.004) between IonTorrent sequencing and pathology review. This suggests that qpure may be a more accurate predictor of tumour cellularity than pathology review. qpure can be downloaded from https://sourceforge.net/projects/qpure/.
Notes:
Andrew V Biankin, Nicola Waddell, Karin S Kassahn, Marie-Claude Gingras, Lakshmi B Muthuswamy, Amber L Johns, David K Miller, Peter J Wilson, Ann-Marie Patch, Jianmin Wu, David K Chang, Mark J Cowley, Brooke B Gardiner, Sarah Song, Ivon Harliwong, Senel Idrisoglu, Craig Nourse, Ehsan Nourbakhsh, Suzanne Manning, Shivangi Wani, Milena Gongora, Marina Pajic, Christopher J Scarlett, Anthony J Gill, Andreia V Pinho, Ilse Rooman, Matthew Anderson, Oliver Holmes, Conrad Leonard, Darrin Taylor, Scott Wood, Christina Xu, Katia Nones, J Lynn Fink, Angelika Christ, Tim Bruxner, Nicole Cloonan, Gabriel Kolle, Felicity Newell, Mark Pinese, R Scott Mead, Jeremy L Humphris, Warren Kaplan, Marc D Jones, Emily K Colvin, Adnan M Nagrial, Emily S Humphrey, Angela Chou, Venessa T Chin, Lorraine A Chantrill, Amanda Mawson, Jaswinder S Samra, James G Kench, Jessica A Lovell, Roger J Daly, Neil D Merrett, Christopher Toon, Krishna Epari, Nam Q Nguyen, Andrew Barbour, Nikolajs Zeps, Australian Pancreatic Cancer Genome Initiative*, Nipun Kakkar, Fengmei Zhao, Yuan Qing Wu, Min Wang, Donna M Muzny, William E Fisher, F Charles Brunicardi, Sally E Hodges, Jeffrey G Reid, Jennifer Drummond, Kyle Chang, Yi Han, Lora R Lewis, Huyen Dinh, Christian J Buhay, Timothy Beck, Lee Timms, Michelle Sam, Kimberly Begley, Andrew Brown, Deepa Pai, Ami Panchal, Nicholas Buchner, Richard De Borja, Robert E Denroche, Christina K Yung, Stefano Serra, Nicole Onetto, Debabrata Mukhopadhyay, Ming-Sound Tsao, Patricia A Shaw, Gloria M Petersen, Steven Gallinger, Ralph H Hruban, Anirban Maitra, Christine A Iacobuzio-Donahue, Richard D Schulick, Christopher L Wolfgang, Richard A Morgan, Rita T Lawlor, Paola Capelli, Vincenzo Corbo, Maria Scardoni, Giampaolo Tortora, Margaret A Tempero, Karen M Mann, Nancy A Jenkins, Pedro A Perez-Mancera, David J Adams, David A Largaespada, Lodewyk F A Wessels, Alistair G Rust, Lincoln D Stein, David A Tuveson, Neal G Copeland, Elizabeth A Musgrove, Aldo Scarpa, James R Eshleman, Thomas J Hudson, Robert L Sutherland, David A Wheeler, John V Pearson, John D McPherson, Richard A Gibbs, Sean M Grimmond (2012)  Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes.   Nature 491: 7424. 399-405 Nov  
Abstract: Pancreatic cancer is a highly lethal malignancy with few effective therapies. We performed exome sequencing and copy number analysis to define genomic aberrations in a prospectively accrued clinical cohort (n = 142) of early (stage I and II) sporadic pancreatic ductal adenocarcinoma. Detailed analysis of 99 informative tumours identified substantial heterogeneity with 2,016 non-silent mutations and 1,628 copy-number variations. We define 16 significantly mutated genes, reaffirming known mutations (KRAS, TP53, CDKN2A, SMAD4, MLL3, TGFBR2, ARID1A and SF3B1), and uncover novel mutated genes including additional genes involved in chromatin modification (EPC1 and ARID2), DNA damage repair (ATM) and other mechanisms (ZIM2, MAP2K4, NALCN, SLC16A4 and MAGEA6). Integrative analysis with in vitro functional data and animal models provided supportive evidence for potential roles for these genetic aberrations in carcinogenesis. Pathway-based analysis of recurrently mutated genes recapitulated clustering in core signalling pathways in pancreatic ductal adenocarcinoma, and identified new mutated genes in each pathway. We also identified frequent and diverse somatic aberrations in genes described traditionally as embryonic regulators of axon guidance, particularly SLIT/ROBO signalling, which was also evident in murine Sleeping Beauty transposon-mediated somatic mutagenesis models of pancreatic cancer, providing further supportive evidence for the potential involvement of axon guidance genes in pancreatic carcinogenesis.
Notes:
Carole M Tactacan, David K Chang, Mark J Cowley, Emily S Humphrey, Jianmin Wu, Anthony J Gill, Angela Chou, Katia Nones, Sean M Grimmond, Robert L Sutherland, Andrew V Biankin, Roger J Daly (2012)  RON is not a prognostic marker for resectable pancreatic cancer.   BMC Cancer 12: 1. Sep  
Abstract: ABSTRACT: BACKGROUND: The receptor tyrosine kinase RON exhibits increased expression during pancreatic cancer progression and promotes migration, invasion and gemcitabine resistance of pancreatic cancer cells in experimental models. However, the prognostic significance of RON expression in pancreatic cancer is unknown. METHODS: RON expression was characterized in several large cohorts, including a prospective study, totaling 492 pancreatic cancer patients and relationships with patient outcome and clinico-pathologic variables were assessed. RESULTS: RON expression was associated with outcome in a training set, but this was not recapitulated in the validation set, nor was there any association with therapeutic responsiveness in the validation set or the prospective study. CONCLUSIONS: Although RON is implicated in pancreatic cancer progression in experimental models, and may constitute a therapeutic target, RON expression is not associated with prognosis or therapeutic responsiveness in resected pancreatic cancer.
Notes:
2011
Thi Thanh Vu, Dominique Gatto, Vivian Turner, Alister P W Funnell, Ka Sin Mak, Laura J Norton, Warren Kaplan, Mark J Cowley, Fabien Agenès, Jörg Kirberg, Robert Brink, Richard C M Pearson, Merlin Crossley (2011)  Impaired B cell development in the absence of Kruppel-like factor 3.   J Immunol 187: 10. 5032-5042 Nov  
Abstract: Krüppel-like factor 3 (Klf3) is a member of the Klf family of transcription factors. Klfs are widely expressed and have diverse roles in development and differentiation. In this study, we examine the function of Klf3 in B cell development by studying B lymphopoiesis in a Klf3 knockout mouse model. We show that B cell differentiation is significantly impaired in the bone marrow, spleen, and peritoneal cavity of Klf3 null mice and confirm that the defects are cell autonomous. In the bone marrow, there is a reduction in immature B cells, whereas recirculating mature cells are noticeably increased. Immunohistology of the spleen reveals a poorly structured marginal zone (MZ) that may in part be caused by deregulation of adhesion molecules on MZ B cells. In the peritoneal cavity, there are significant defects in B1 B cell development. We also report that the loss of Klf3 in MZ B cells is associated with reduced BCR signaling strength and an impaired ability to respond to LPS stimulation. Finally, we show increased expression of a number of Klf genes in Klf3 null B cells, suggesting that a Klf regulatory network may exist in B cells.
Notes:
Vivek A Bhadri, Mark J Cowley, Warren Kaplan, Toby N Trahair, Richard B Lock (2011)  Evaluation of the NOD/SCID xenograft model for glucocorticoid-regulated gene expression in childhood B-cell precursor acute lymphoblastic leukemia.   BMC Genomics 12: 11  
Abstract: Glucocorticoids such as prednisolone and dexamethasone are critical drugs used in multi-agent chemotherapy protocols used to treat acute lymphoblastic leukemia (ALL), and response to glucocorticoids is highly predictive of outcome. The NOD/SCID xenograft mouse model of ALL is a clinically relevant model in which the mice develop a systemic leukemia which retains the fundamental biological characteristics of the original disease. Here we report a study evaluating the NOD/SCID xenograft mouse model to investigate glucocorticoid-induced gene expression. Cells from a glucocorticoid-sensitive xenograft derived from a child with B-cell precursor ALL were inoculated into NOD/SCID mice. When highly engrafted the mice were randomized into groups of 4 to receive dexamethasone 15 mg/kg by intraperitoneal injection or vehicle control. Leukemia cells were harvested from mice spleens at 0, 8, 24 or 48 hours thereafter, and gene expression analyzed on Illumina WG-6_V3 chips, comparing all groups to time 0 hours.
Notes:
Charmaine S Tam, Leonie K Heilbronn, Corneliu Henegar, Melanie Wong, Christopher T Cowell, Mark J Cowley, Warren Kaplan, Karine Clément, Louise A Baur (2011)  An early inflammatory gene profile in visceral adipose tissue in children.   Int J Pediatr Obes 6: 2-2. e360-e363 Jun  
Abstract: The aim of this study was to characterize expression profiles of visceral and subcutaneous adipose tissue in children. Adipose tissue samples were collected from children having elective surgery (n = 71, [54 boys], 6.0 ± 4.3 years). Affymetrix microarrays (n = 20) were performed to characterize the functional profile and identify genes of interest in adipose tissue. Visceral adipose tissue had an overrepresentation of Gene Ontology themes related to immune and inflammatory responses and subcutaneous adipose tissue had an overrepresentation of themes related to adipocyte growth and development. Likewise, qPCR performed in the whole cohort showed a 30-fold increase in haptoglobin (P = 0.005), 7-fold increase in IL-10 (P < 0.001), 8-fold decrease in VEGF (P = 0.01) and a 28-fold decrease in TBOX15 (P < 0.001) in visceral compared to subcutaneous adipose tissue. The inflammatory pattern in visceral adipose tissue may represent an early stage of the adverse effects of this depot, and combined with chronic obesity, may contribute to increased metabolic and cardiovascular risk.
Notes:
Cheryl C Y Li, Jennifer E Cropley, Mark J Cowley, Thomas Preiss, David I K Martin, Catherine M Suter (2011)  A sustained dietary change increases epigenetic variation in isogenic mice.   PLoS Genet 7: 4. Apr  
Abstract: Epigenetic changes can be induced by adverse environmental exposures, such as nutritional imbalance, but little is known about the nature or extent of these changes. Here we have explored the epigenomic effects of a sustained nutritional change, excess dietary methyl donors, by assessing genomic CpG methylation patterns in isogenic mice exposed for one or six generations. We find stochastic variation in methylation levels at many loci; exposure to methyl donors increases the magnitude of this variation and the number of variable loci. Several gene ontology categories are significantly overrepresented in genes proximal to these methylation-variable loci, suggesting that certain pathways are susceptible to environmental influence on their epigenetic states. Long-term exposure to the diet (six generations) results in a larger number of loci exhibiting epigenetic variability, suggesting that some of the induced changes are heritable. This finding presents the possibility that epigenetic variation within populations can be induced by environmental change, providing a vehicle for disease predisposition and possibly a substrate for natural selection.
Notes:
Peter D Campbell, Anita Weinberg, Jonathan Chee, Lina Mariana, Rochelle Ayala, Wayne J Hawthorne, Philip J O'Connell, Thomas Loudovaris, Mark J Cowley, Thomas W Kay, Shane T Grey, Helen E Thomas (2011)  Expression of pro- and anti-apoptotic molecules of the Bcl-2 family in human islets post-isolation.   Cell Transplant Apr  
Abstract: Human islets are subjected to a number of stresses before and during their isolation that may influence their survival and engraftment after transplantation. Apoptosis is likely to be activated in response to these stresses. Apoptosis due to intrinsic stresses is regulated by pro- and anti-apoptotic members of the Bcl-2 family. While the role of the Bcl-2 family in apoptosis of rodent islets is becoming increasingly understood, little is known about which of these molecules are expressed or required for apoptosis of human islets. This study investigated the expression of the Bcl-2 family of molecules in isolated human islets. RNA and protein lysates were extracted from human islets immediately post-isolation. At the same time, standard quality control assays including viability staining and beta cell content were performed on each islet preparation. Microarrays, RT-PCR and western blotting were performed on islet RNA and protein. The pro-survival molecules Bcl-xl and Mcl-1, but not Bcl-2 were highly expressed. The multi-domain pro-apoptotic effector molecule Bax was expressed at higher levels than Bak. Pro-apoptotic BH3-only molecules were expressed at low levels, with Bid being the most abundant. The pro-apoptotic molecules BNIP3, BNIP3L and Beclin-1 were all highly expressed indicating exposure of islets to oxygen and nutrient deprivation during isolation. Our data provide a comprehensive analysis of expression levels of pro- and anti-apoptotic Bcl-2 family members in isolated human islets. Knowledge of which molecules are expressed will guide future research to understand the apoptotic pathways activated during isolation or after transplantation. This is crucial for the design of methods to achieve improved transplantation outcomes.
Notes:
Jing Ting Zhao, Mark J Cowley, Paul Lee, Vita Birzniece, Warren Kaplan, Ken K Y Ho (2011)  Identification of novel GH-regulated pathway of lipid metabolism in adipose tissue: a gene expression study in hypopituitary men.   J Clin Endocrinol Metab 96: 7. E1188-E1196 Jul  
Abstract: Adipose tissue is a major target of GH action. GH stimulates lipolysis and reduces fat mass. The molecular mechanism underlying cellular and metabolic effects of GH in adipose tissue is not well understood.
Notes:
Lucy Jankova, Charles Chan, Caroline L S Fung, Xiaomin Song, Sun Y Kwun, Mark J Cowley, Warren Kaplan, Owen F Dent, Elie L Bokey, Pierre H Chapuis, Mark S Baker, Graham R Robertson, Stephen J Clarke, Mark P Molloy (2011)  Proteomic comparison of colorectal tumours and non-neoplastic mucosa from paired patient samples using iTRAQ mass spectrometry.   Mol Biosyst 7: 11. 2997-3005 Nov  
Abstract: Quantitative mass spectrometry using iTRAQ was used to identify differentially expressed proteins from 16 colorectal cancer (CRC) tumours compared to patient-paired adjacent normal mucosa. Over 1400 proteins were identified and quantitated, with 118 determined as differentially expressed by >1.3-fold, with false discovery rate < 0.05. Gene Ontology analysis indicated that proteins with increased expression levels in CRC tumours include those associated with glycolysis, calcium binding, and protease inhibition. Proteins with reduced levels in CRC tumours were associated with loss of ATP production through: (i) reduced β-oxidation of fatty acids, (ii) reduced NADH production by the tricarboxylic acid cycle and (iii) decreased oxidative phosphorylation activity. Additionally, biosyntheses of glycosaminoglycans and proteoglycans were significantly reduced in tumour samples. Validation experiments using immunoblotting and immunohistochemistry (IHC) showed strong concordance with iTRAQ data suggesting that this workflow is suitable for identifying biomarker candidates. We discuss the uses and challenges of this approach to generate biomarker leads for patient prognostication.
Notes:
2010
Marcel W Coolen, Clare Stirzaker, Jenny Z Song, Aaron L Statham, Zena Kassir, Carlos S Moreno, Andrew N Young, Vijay Varma, Terence P Speed, Mark Cowley, Paul Lacaze, Warren Kaplan, Mark D Robinson, Susan J Clark (2010)  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.   Nat Cell Biol 12: 3. 235-246 Mar  
Abstract: Silencing of individual genes can occur by genetic and epigenetic processes during carcinogenesis, but the underlying mechanisms remain unclear. By creating an integrated prostate cancer epigenome map using tiling arrays, we show that contiguous regions of gene suppression commonly occur through long-range epigenetic silencing (LRES). We identified 47 LRES regions in prostate cancer, typically spanning about 2 Mb and harbouring approximately 12 genes, with a prevalence of tumour suppressor and miRNA genes. Our data reveal that LRES is associated with regional histone deacetylation combined with subdomains of different epigenetic remodelling patterns, which include re-enforcement, gain or exchange of repressive histone, and DNA methylation marks. The transcriptional and epigenetic state of genes in normal prostate epithelial and human embryonic stem cells can play a critical part in defining the mode of cancer-associated epigenetic remodelling. We propose that consolidation or effective reduction of the cancer genome commonly occurs in domains through a combination of LRES and LOH or genomic deletion, resulting in reduced transcriptional plasticity within these regions.
Notes:
Jia Li, Daniel M-Y Sze, Ross D Brown, Mark J Cowley, Warren Kaplan, Sui-Lin Mo, Shihong Yang, Esther Aklilu, Karieshma Kabani, Yen S Loh, Tetsuo Yamagishi, Yuling Chen, P Joy Ho, Douglas E Joshua (2010)  Clonal expansions of cytotoxic T cells exist in the blood of patients with Waldenstrom macroglobulinemia but exhibit anergic properties and are eliminated by nucleoside analogue therapy.   Blood 115: 17. 3580-3588 Apr  
Abstract: T cells contribute to host-tumor interactions in patients with monoclonal gammopathies. Expansions of CD8(+)CD57(+) T-cell receptor Vbeta-positive (TCRVbeta(+))-restricted cytotoxic T-cell (CTL) clones are found in 48% of patients with multiple myeloma and confer a favorable prognosis. We now report that CTL clones with varying TCRVbeta repertoire are present in 70% of patients with Waldenström macroglobulinemia (WM; n = 20). Previous nucleoside analog (NA) therapy, associated with increased incidence of transformation to aggressive lymphoma, significantly influenced the presence of TCRVbeta expansions (chi(2) = 11.6; P < .001), as 83% of patients without (n = 6) and only 7% with (n = 14) TCRVbeta expansions had received NA. Clonality of CD3(+)CD8(+)CD57(+)TCRVbeta(+)-restricted CTLs was confirmed by TCRVbeta CDR3 size analysis and direct sequencing. The differential expression of CD3(+)CD8(+)CD57(+)TCRVbeta(+) cells was profiled using DNA microarrays and validated at mRNA and protein level. By gene set enrichment analysis, CTL clones expressed not only genes from cytotoxic pathways (GZMB, PRF1, FGFBP2) but also genes that suppress apoptosis, inhibit proliferation, arrest cell-cycle G1/S transition, and activate T cells (RAS, CSK, and TOB pathways). Proliferation tracking after stimulation confirmed their anergic state. Our studies demonstrate the incidence, NA sensitivity, and nature of clonal CTLs in WM and highlight mechanisms that cause anergy in these cells.
Notes:
Lily Ting, Timothy J Williams, Mark J Cowley, Federico M Lauro, Michael Guilhaus, Mark J Raftery, Ricardo Cavicchioli (2010)  Cold adaptation in the marine bacterium, Sphingopyxis alaskensis, assessed using quantitative proteomics.   Environ Microbiol 12: 10. 2658-2676 Oct  
Abstract: The cold marine environment constitutes a large proportion of the Earth's biosphere. Sphingopyxis alaskensis was isolated as a numerically abundant bacterium from several cold marine locations, and has been extensively studied as a model marine bacterium. Recently, a metabolic labelling platform was developed to comprehensively identify and quantify proteins from S. alaskensis. The approach incorporated data normalization and statistical validation for the purpose of generating highly confident quantitative proteomics data. Using this approach, we determined quantitative differences between cells grown at 10°C (low temperature) and 30°C (high temperature). Cold adaptation was linked to specific aspects of gene expression: a dedicated protein-folding system using GroESL, DnaK, DnaJ, GrpE, SecB, ClpB and PPIase; polyhydroxyalkanoate-associated storage materials; a link between enzymes in fatty acid metabolism and energy generation; de novo synthesis of polyunsaturated fatty acids in the membrane and cell wall; inorganic phosphate ion transport by a phosphate import PstB homologue; TonB-dependent receptor and bacterioferritin in iron homeostasis; histidine, tryptophan and proline amino acid metabolism; and a large number of proteins without annotated functions. This study provides a new level of understanding on how important marine bacteria can adapt to compete effectively in cold marine environments. This study is also a benchmark for comparative proteomic analyses with other important marine bacteria and other cold-adapted organisms.
Notes:
H N Hilton, M Kalyuga, M J Cowley, M C Alles, H J Lee, C E Caldon, K Blazek, W Kaplan, E A Musgrove, R J Daly, M J Naylor, J D Graham, C L Clarke, C J Ormandy (2010)  The antiproliferative effects of progestins in T47D breast cancer cells are tempered by progestin induction of the ETS transcription factor Elf5.   Mol Endocrinol 24: 7. 1380-1392 Jul  
Abstract: Prolactin and progesterone act together to regulate mammary alveolar development, and both hormones have been implicated in breast cancer initiation and progression. Here we show that Elf5, a prolactin-induced ETS transcription factor that specifies the mammary secretory cell lineage, is also induced by progestins in breast cancer cells via a direct mechanism. To define the transcriptional response to progestin elicited via Elf5, we made an inducible Elf5 short hairpin-RNA knock-down model in T47D breast cancer cells and used it to prevent the progestin-induction of Elf5. Functional analysis of Affymetrix gene expression data using Gene Ontologies and Gene Set Enrichment Analysis showed enhancement of the progestin effects on cell cycle gene expression. Cell proliferation assays showed a more efficacious progestin-induced growth arrest when Elf5 was kept at baseline levels. These results showed that progestin induction of Elf5 expression tempered the antiproliferative effects of progestins in T47D cells, providing a further mechanistic link between prolactin and progestin in the regulation of mammary cell phenotype.
Notes:
2009
Christopher J Mitchell, Anne E Nelson, Mark J Cowley, Warren Kaplan, Glenn Stone, Selina K Sutton, Amie Lau, Carol M Y Lee, Ken K Y Ho (2009)  Detection of growth hormone doping by gene expression profiling of peripheral blood.   J Clin Endocrinol Metab 94: 12. 4703-4709 Dec  
Abstract: GH abuse is a significant problem in many sports, and there is currently no robust test that allows detection of doping beyond a short window after administration.
Notes:
Lily Ting, Mark J Cowley, Seah Lay Hoon, Michael Guilhaus, Mark J Raftery, Ricardo Cavicchioli (2009)  Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling.   Mol Cell Proteomics 8: 10. 2227-2242 Oct  
Abstract: Comparative proteomics is a powerful analytical method for learning about the responses of biological systems to changes in growth parameters. To make confident inferences about biological responses, proteomics approaches must incorporate appropriate statistical measures of quantitative data. In the present work we applied microarray-based normalization and statistical analysis (significance testing) methods to analyze quantitative proteomics data generated from the metabolic labeling of a marine bacterium (Sphingopyxis alaskensis). Quantitative data were generated for 1,172 proteins, representing 1,736 high confidence protein identifications (54% genome coverage). To test approaches for normalization, cells were grown at a single temperature, metabolically labeled with (14)N or (15)N, and combined in different ratios to give an artificially skewed data set. Inspection of ratio versus average (MA) plots determined that a fixed value median normalization was most suitable for the data. To determine an appropriate statistical method for assessing differential abundance, a -fold change approach, Student's t test, unmoderated t test, and empirical Bayes moderated t test were applied to proteomics data from cells grown at two temperatures. Inverse metabolic labeling was used with multiple technical and biological replicates, and proteomics was performed on cells that were combined based on equal optical density of cultures (providing skewed data) or on cell extracts that were combined to give equal amounts of protein (no skew). To account for arbitrarily complex experiment-specific parameters, a linear modeling approach was used to analyze the data using the limma package in R/Bioconductor. A high quality list of statistically significant differentially abundant proteins was obtained by using lowess normalization (after inspection of MA plots) and applying the empirical Bayes moderated t test. The approach also effectively controlled for the number of false discoveries and corrected for the multiple testing problem using the Storey-Tibshirani false discovery rate (Storey, J. D., and Tibshirani, R. (2003) Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. U.S.A. 100, 9440-9445). The approach we have developed is generally applicable to quantitative proteomics analyses of diverse biological systems.
Notes:
Mark J Cowley, Chris J Cotsapas, Rohan B H Williams, Eva K F Chan, Jeremy N Pulvers, Michael Y Liu, Oscar J Luo, David J Nott, Peter F R Little (2009)  Intra- and inter-individual genetic differences in gene expression.   Mamm Genome 20: 5. 281-295 May  
Abstract: Genetic variation is known to influence the amount of mRNA produced by a gene. Because molecular machines control mRNA levels of multiple genes, we expect genetic variation in components of these machines would influence multiple genes in a similar fashion. We show that this assumption is correct by using correlation of mRNA levels measured from multiple tissues in mouse strain panels to detect shared genetic influences. These correlating groups of genes (CGGs) have collective properties that on average account for 52-79% of the variability of their constituent genes and can contain genes that encode functionally related proteins. We show that the genetic influences are essentially tissue-specific and, consequently, the same genetic variations in one animal may upregulate a CGG in one tissue but downregulate the CGG in a second tissue. We further show similarly paradoxical behaviour of CGGs within the same tissues of different individuals. Thus, this class of genetic variation can result in complex inter- and intraindividual differences. This will create substantial challenges in humans, where multiple tissues are not readily available.
Notes:
2008
Benjamin M P Tang, Anthony S McLean, Ian W Dawes, Stephen J Huang, Mark J Cowley, Ruby C Y Lin (2008)  Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients.   Crit Care Med 36: 4. 1125-1128 Apr  
Abstract: It is unclear whether the host response of gram-positive sepsis differs from gram-negative sepsis at a transcriptome level. Using microarray technology, we compared the gene-expression profiles of gram-positive sepsis and gram-negative sepsis in critically ill patients.
Notes:
2007
David J Nott, Zeming Yua, Eva Chan, Chris Cotsapas, Mark J Cowley, Jeremy Pulvers, Rohan Williams, Peter Little (2007)  Hierarchical Bayes variable selection and microarray experiments   Journal of Multivariate Analysis 98: 4. 852-872 April  
Abstract: Hierarchical and empirical Bayes approaches to inference are attractive for data arising from microarray gene expression studies because of their ability to borrow strength across genes in making inferences. Here we focus on the simplest case where we have data from replicated two colour arrays which compare two samples and where we wish to decide which genes are differentially expressed and obtain estimates of operating characteristics such as false discovery rates. The purpose of this paper is to examine the frequentist performance of Bayesian variable selection approaches to this problem for different prior specifications and to examine the effect on inference of commonly used empirical Bayes approximations to hierarchical Bayes procedures. The paper makes three main contributions. First, we describe how the log odds of differential expression can usually be computed analytically in the case where a double tailed exponential prior is used for gene effects rather than a normal prior, which gives an alternative to the commonly used B-statistic for ranking genes in simple comparative experiments. The second contribution of the paper is to compare empirical Bayes procedures for detecting differential expression with hierarchical Bayes methods which account for uncertainty in prior hyperparameters to examine how much is lost in using the commonly employed empirical Bayes approximations. Third, we describe an efficient MCMC scheme for carrying out the computations required for the hierarchical Bayes procedures. Comparisons are made via simulation studies where the simulated data are obtained by fitting models to some real microarray data sets. The results have implications for analysis of microarray data using parametric hierarchical and empirical Bayes methods for more complex experimental designs: generally we find that the empirical Bayes methods work well, which supports their use in the analysis of more complex experiments when a full hierarchical Bayes analysis would impose heavy computational demands.
Notes:
Rohan B H Williams, Eva K F Chan, Mark J Cowley, Peter F R Little (2007)  The influence of genetic variation on gene expression.   Genome Res 17: 12. 1707-1716 Dec  
Abstract: The view that changes to the control of gene expression rather than alterations to protein sequence are central to the evolution of organisms has become something of a truism in molecular biology. In reality, the direct evidence for this is limited, and only recently have we had the ability to look more globally at how genetic variation influences gene expression, focusing upon inter-individual variation in gene expression and using microarrays to test for differences in mRNA levels. Here, we review the scope of these experimental analyses, what they are designed to tell us about genetic variation, and what are their limitations from both a technical and a conceptual viewpoint. We conclude that while we are starting to understand the impact of this class of genetic variation upon steady-state mRNA levels, we are still far from identifying the potential phenotypic and evolutionary outcomes.
Notes:
2006
Chris J Cotsapas, Rohan B H Williams, Jeremy N Pulvers, David J Nott, Eva K F Chan, Mark J Cowley, Peter F R Little (2006)  Genetic dissection of gene regulation in multiple mouse tissues.   Mamm Genome 17: 6. 490-495 Jun  
Abstract: The analysis of the influence of genetic variation on regulation of gene expression at a near-genome-wide level has become the focus of much recent interest. It is widely appreciated that many genes are expressed in a tissue-specific manner and that others are more ubiquitously expressed but relatively little is known about how genetic variation might influence these tissue patterns of gene expression. In this review we discuss what is known about the tissue specificity of the influence of genetic variation and review the challenges that we face in combining hugely parallel, microarray-based gene analysis with equally expensive genetic analysis. We conclude that the available data suggest that genetic variation is essentially tissue specific in its effects upon gene expression and this has important implications for experimental analysis.
Notes:

PhD theses

2008
Mark J Cowley (2008)  The effects of regulatory variation in multiple mouse tissues   School of Biotechnology and Biomolecular Sciences The University of New South Wales, Sydney, Australia School of Biotechnology and Biomolecular Sciences The University of New South Wales Sydney NSW 2052 Australia:  
Abstract: Recently, it has been shown that genetic variation that perturbs the regulation of gene ex- pression is widespread in eukaryotic genomes. Regulatory variation (RV) is expected to be an important driver of phenotypic differences, evolutionary change, and susceptibility to complex genetic diseases. Because trans-acting regulators of gene expression control mRNA levels of multiple genes simultaneously, we hypothesise that RV that affects these components will have a shared-influence upon the expression levels of multiple genes. Since genes are regulated in trans by combinations of basal and tissue specific factors, we further hypothesise that RV in these components may have different effects in each tissue. We used microarrays to identify 755 genes that were affected by RV in at least one of the brain, kidney and liver of two inbred mouse strains, C57BL/6J and DBA/2J. Just 2% were affected in all three tissues, suggesting that the influence of RV is predominantly tissue specific. To study shared-RV, we measured the expression levels of these 755 genes in the same 3 tissues from a panel of recombinant inbred mice, and identified groups of correlated genes that are putatively under the influence of shared trans-acting RV. Using methods that we developed for studying the effects of RV in multiple tissues, we identified 212 genes that are correlated in all three tissues, which include 10 groups of at least 3 genes. We developed a novel method called coherency analysis to show that RV consistently affected the expression levels of these groups of genes in different genetic backgrounds. Strikingly, the relative up- or down-regulation of genes in each group was markedly different in the three tissues of the same mouse, suggesting that the influence of RV itself is not tissue specific as previously expected, but that RV can influence genes with differing outcomes in each tissue. These observations are compatible with RV affecting combinations of basal and tissue specific regulatory factors. This is the first cross-tissue investigation into the influence of shared- RV in multiple tissues, which has important implications in humans, where access to the phenotypically relevant tissue may be necessarily limited.
Notes:
Powered by PublicationsList.org.